Squarepoint’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-100,300
Closed -$2.34M 4539
2026
Q1
$2.34M Buy
100,300
+79,400
+380% +$2.47M ﹤0.01% 2066
2025
Q4
$925K Buy
20,900
+3,200
+18% +$180K ﹤0.01% 2683
2025
Q3
$1.29M Sell
17,700
-19,800
-53% -$1.29M ﹤0.01% 2459
2025
Q2
$2.3M Buy
37,500
+3,700
+11% +$206K ﹤0.01% 2001
2025
Q1
$1.96M Sell
33,800
-71,900
-68% -$4.54M ﹤0.01% 2105
2024
Q4
$5.64M Buy
+105,700
New +$5.18M 0.01% 1539

Other funds holding DOCS

Squarepoint's DOCS Position: Q2 2026 in Review

Squarepoint increased its Doximity (DOCS) stake by 180% in Q2 2026, buying an estimated $30.9M and bringing the position to 2,174,076 shares worth $45.1M. The position accounts for 0.05% of the portfolio, ranked #366.

Squarepoint first reported a position in DOCS in Q2 2021 and has held it in 17 quarters since. The position peaked at $75.8M in Q3 2025. 358 funds tracked by Wall St. Rank hold DOCS as of Q2 2026.

  • Squarepoint held 2,174,076 shares of Doximity worth $45.1M as of Q2 2026.
  • Squarepoint bought 1,398,061 Doximity shares in Q2 2026, an estimated $30.9M.
  • Doximity made up 0.05% of Squarepoint's portfolio in Q2 2026, its #366 holding.
  • Squarepoint first reported a position in Doximity in Q2 2021 and has held it in 17 quarters since.
  • Squarepoint's Doximity position peaked at $75.8M in Q3 2025.
  • 358 funds tracked by Wall St. Rank held Doximity as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.